Tolosa E - Search Results

1

α-Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients.

de Mena L, Parés G, Garrido A, Pilco-Janeta DF, Fernández M, Pérez J, Tolosa E, Cámara A, Valldeoriola F, Ezquerra M, Martí MJ, Fernández-Santiago R; Barcelona LRRK2 Study Group. de Mena L, et al. Among authors: tolosa e. Mov Disord. 2024 Dec 23. doi: 10.1002/mds.30094. Online ahead of print. Mov Disord. 2024. PMID: 39711195

2

α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.

Fernández-Santiago R, Garrido A, Infante J, González-Aramburu I, Sierra M, Fernández M, Valldeoriola F, Muñoz E, Compta Y, Martí MJ, Ríos J, Tolosa E, Ezquerra M; Barcelona LRRK2 Study Group†. Fernández-Santiago R, et al. Among authors: tolosa e. Mov Disord. 2018 Apr;33(4):637-641. doi: 10.1002/mds.27295. Epub 2018 Feb 23. Mov Disord. 2018. PMID: 29473656

3

Differential Phospho-Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease.

Garrido A, Santamaría E, Fernández-Irigoyen J, Soto M, Simonet C, Fernández M, Obiang D, Tolosa E, Martí MJ, Padmanabhan S, Malagelada C, Ezquerra M, Fernández-Santiago R. Garrido A, et al. Among authors: tolosa e. Mov Disord. 2022 May;37(5):1004-1015. doi: 10.1002/mds.28927. Epub 2022 Jan 20. Mov Disord. 2022. PMID: 35049090 Free PMC article.

4

Brain and Cerebrospinal Fluid α-Synuclein Real-Time Quaking-Induced Conversion Identifies Lewy Body Pathology in LRRK2-PD.

Garrido A, Fairfoul G, Tolosa E, Marti MJ, Ezquerra M, Green AJE. Garrido A, et al. Among authors: tolosa e. Mov Disord. 2023 Feb;38(2):333-338. doi: 10.1002/mds.29284. Epub 2022 Dec 5. Mov Disord. 2023. PMID: 36471633

5

Striated anal sphincter denervation in patients with progressive supranuclear palsy.

Valldeoriola F, Valls-Solé J, Tolosa ES, Marti MJ. Valldeoriola F, et al. Among authors: tolosa es. Mov Disord. 1995 Sep;10(5):550-5. doi: 10.1002/mds.870100504. Mov Disord. 1995. PMID: 8552104

6

Postural and action myoclonus in patients with parkinsonian type multiple system atrophy.

Salazar G, Valls-Solé J, Martí MJ, Chang H, Tolosa ES. Salazar G, et al. Among authors: tolosa es. Mov Disord. 2000 Jan;15(1):77-83. doi: 10.1002/1531-8257(200001)15:1<77::aid-mds1013>3.0.co;2-n. Mov Disord. 2000. PMID: 10634245

7

Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients.

Valldeoriola F, Pilleri M, Tolosa E, Molinuevo JL, Rumià J, Ferrer E. Valldeoriola F, et al. Among authors: tolosa e. Mov Disord. 2002 Jan;17(1):125-32. doi: 10.1002/mds.1278. Mov Disord. 2002. PMID: 11835449

8

Further extension of the H1 haplotype associated with progressive supranuclear palsy.

Pastor P, Ezquerra M, Tolosa E, Muñoz E, Martí MJ, Valldeoriola F, Molinuevo JL, Calopa M, Oliva R. Pastor P, et al. Among authors: tolosa e. Mov Disord. 2002 May;17(3):550-6. doi: 10.1002/mds.10076. Mov Disord. 2002. PMID: 12112206

9

Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.

Alegret M, Valldeoriola F, Martí M, Pilleri M, Junqué C, Rumià J, Tolosa E. Alegret M, et al. Among authors: tolosa e. Mov Disord. 2004 Dec;19(12):1463-9. doi: 10.1002/mds.20237. Mov Disord. 2004. PMID: 15390065

10

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.

Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E. Gaig C, et al. Among authors: tolosa e. Arch Neurol. 2006 Mar;63(3):377-82. doi: 10.1001/archneur.63.3.377. Arch Neurol. 2006. PMID: 16533964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters